Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | PRKCA | P17252 | 1/20 | 0.37 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.37 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.37 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.37 |
| ▸ | TLR2 | O60603 | 7/20 | 0.37 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.36 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.36 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29322919 | 0.97 | ALDH1A1 (0.41) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL29323882 | 0.94 | ALDH1A1 (0.43) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL29322751 | 0.94 | ALDH1A1 (0.43) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL29322673 | 0.89 | ALDH1A1 (0.41) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL29322915 | 0.88 | KDM4E (0.40) | LMNALPAR3LPAR1ENPP2 | |
| SCHEMBL29322411 | 0.88 | ALDH1A1 (0.39) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL29322840 | 0.86 | LMNA (0.39) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL6569812 | 0.80 | PRKCA (0.50) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL29323161 | 0.79 | ALDH1A1 (0.52) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL29320969 | 0.79 | ALDH1A1 (0.52) | ALDH1A1LMNAPRKCAPRKCEPRKCQ |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4400491-A1 | NOVEL LIPIDS USED FOR NUCLEIC ACID DELIVERY AND LIPID NANOPARTICLE COMPOSITION | Themedium Therapeutics Co., Ltd (CN) | 2024-07-17 | — | — | EP | disclosed |